Susquehanna Fundamental Investments’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-21,900	Closed	-$273K	–	1661
2021 Q4	$273K	Buy	+21,900	New	+$273K	0.01%	1144